Nagata Yasuo, Mizuta Narumi, Kanasaki Akane, Tanaka Kazunari
Department of Nutrition, University of Nagasaki, Siebold, Nagasaki, Japan.
Center for Industry, University and Government Cooperation, Nagasaki University, Nagasaki, Japan.
J Sci Food Agric. 2018 Mar;98(5):2020-2026. doi: 10.1002/jsfa.8687. Epub 2017 Nov 3.
Rare sugars including d-allulose, d-tagatose, and d-sorbose are present in limited quantities in nature; some of these rare sugars are now commercially produced using microbial enzymes. Apart from the anti-obesity and anti-hyperglycaemic activities of d-allulose, effects of these sugars on lipid metabolism have not been investigated. Therefore, we aimed to determine if and how d-tagatose and d-sorbose modulate lipid metabolism in rats. After feeding these rare sugars to rats, parameters on lipid metabolism were determined.
No diet-related effects were observed on body weight and food intake. Hepatic lipogenic enzyme activity was lowered by d-allulose and d-sorbose but increased by d-tagatose. Faecal fatty acid excretion was non-significantly decreased by d-allulose, but significantly increased by d-sorbose without affecting faecal steroid excretion. A trend toward reduced adipose tissue weight was observed in groups fed rare sugars. Serum adiponectin levels were decreased by d-sorbose relative to the control. Gene expression of cholesterol metabolism-related liver proteins tended to be down-regulated by d-allulose and d-sorbose but not by d-tagatose. In the small intestine, SR-B1 mRNA expression was suppressed by d-sorbose.
Lipid metabolism in rats varies with rare sugars. Application of rare sugars to functional foods for healthy body weight maintenance requires further studies. © 2017 Society of Chemical Industry.
包括d-阿洛酮糖、d-塔格糖和d-山梨糖在内的稀有糖在自然界中含量有限;其中一些稀有糖现在通过微生物酶进行商业生产。除了d-阿洛酮糖的抗肥胖和抗高血糖活性外,这些糖对脂质代谢的影响尚未得到研究。因此,我们旨在确定d-塔格糖和d-山梨糖是否以及如何调节大鼠的脂质代谢。在给大鼠喂食这些稀有糖后,测定了脂质代谢参数。
未观察到与饮食相关的体重和食物摄入量变化。d-阿洛酮糖和d-山梨糖降低了肝脏生脂酶活性,但d-塔格糖使其升高。d-阿洛酮糖使粪便脂肪酸排泄量略有下降,d-山梨糖使其显著增加,且不影响粪便类固醇排泄。在喂食稀有糖的组中观察到脂肪组织重量有减轻趋势。与对照组相比,d-山梨糖降低了血清脂联素水平。d-阿洛酮糖和d-山梨糖使胆固醇代谢相关肝脏蛋白的基因表达有下调趋势,但d-塔格糖无此作用。在小肠中,d-山梨糖抑制了SR-B1 mRNA的表达。
大鼠的脂质代谢因稀有糖而异。将稀有糖应用于功能性食品以维持健康体重需要进一步研究。© 2017化学工业协会。